Navalgunda Surekha1
BACKGROUND: Systemic Lupus Erythematosus is one of the common autoimmune diseases seen in young patients, predominantly affecting females.
OBJECTIVES: The purpose of this prospective study is to determine ocular presentations in SLE
METHODS: In this descriptive, prospective, observational, cross sectional study, all patients who presented to the department of dermatology during this study period of 12 months from January 2010-December 2010 in Belgaum Institute of Medical Sciences were included.
RESULTS: Total number of females in the present study was 19(74%), males in the study was 6 (26%). Mean age of the patients was 26.2 ± 2.8 (SD) years, maximum age being 36 years and minimum age being 20 years, number of patients in the age group 20-25 years was 14 (56%), 26-30 years was 6 (24%), 30-35 years was 3 (12%), number of patients in 36-40 years was 2 (8%) Maximum number of patients was in their middle age between 20-25 years. Ocular symptoms in present study scelritis was seen in 8(32%) patients, episcelritis was seen in 10(40%) patients, conjunctivitis was seen in 5(20%) patients, ANA-positive was seen in 20 (80%) patients, episcelritis was seen in maximum number of patients i.e. 10 (40%). Distribution of ocular symptoms in present study between two eyes, scelritis was seen in 6(75%) in right eye, was seen in 2(25%) in left eye, scelritis was seen in 7(70%) in right eye, was seen in 3(30%) in left eye, conjunctivitis was seen in scelritis was seen in 2 (40%) in right eye, was seen in 3(60%) in left eye. Ocular symptoms and sex distribution, scelritis was seen in 6 (31.57%) patients in females, Episcelritis was seen in 8(42.10%) females, Conjunctivitis was seen in 5(26.31%) males, and ANA positivity was seen in 18 (72%) females. Scelritis was seen in 2 (33.33%) patients in males, Episcelritis was seen in 2 (33.33%) males, Conjunctivitis was not seen in males, and ANA positivity was seen in 2 (8%) males. P value of all ocular symptoms is insignificant. P-value being insignificant.
CONCLUSION: There is significant percentage of patients who report with dermatological manifestations with SLE predominantly episcelritis.
